KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fat stem cells infused into kidney artery to fight transplant rejection
Disease control CompletedThis early-stage trial tests whether a single infusion of stem cells from donated fat tissue can safely treat rejection in kidney transplant recipients. The cells are delivered directly into the kidney artery. The study includes 12 adults with biopsy-proven rejection and aims to …
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
New hope for kidney transplant patients: drug may prevent rejection with fewer side effects
Disease control CompletedThis study tested a new medicine called tegoprubart in 127 people who received a kidney transplant. The goal was to see if it works better than the standard drug tacrolimus at preventing the body from rejecting the new kidney. Participants took the study drug and were monitored f…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Eledon Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Harmless virus levels may predict transplant complications
Knowledge-focused CompletedThis study looked at 172 kidney transplant recipients who were on stable anti-rejection medication for at least 3 months. Researchers measured levels of a common, harmless virus (Torque Teno Virus) in their blood to see if it could predict serious infections or organ rejection. T…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC